NewslettersCell Therapy News In Vivo Manufacture and Manipulation of CAR-T Cells for Better Druggability By lbeveridge - April 15, 2024 0 The utilization of genetically modified vectors enables in vivo production of CAR-T cells, thereby abbreviating or skipping the lengthy in vitro expansion process. [Cancer And Metastasis Reviews] Abstract